Experience in administration of membrane stabilizers and antihypoxants in patients with pseudoallergic reactions (clinical case)

Sergeeva T.A.; Zhiganova T.A.

doi:https://doi.org/10.17116/klinderma2016156111-115

Sergeeva T.A.

FGOU VFO «Sankt-Peterburgskij gosudarstvennyj universitet», Sankt-Peterburg, Rossija, 199034;
FGBUZ «Sankt-Peterburgskaja klinicheskaja bol'nitsa Rossijskoj akademii nauk», Sankt-Peterburg, Rossija, 194017

Zhiganova T.A.

SPbGBUZ «Psihonevrologicheskij dispanser №5», Sankt-Peterburg, Rossija, 195176

Experience in administration of membrane stabilizers and antihypoxants in patients with pseudoallergic reactions (clinical case)

Authors:

Sergeeva T.A., Zhiganova T.A.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2016;15(6): 111‑115

DOI: 10.17116/klinderma2016156111-115

Read: 26348 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Sergeeva TA, Zhiganova TA. Experience in administration of membrane stabilizers and antihypoxants in patients with pseudoallergic reactions (clinical case). Russian Journal of Clinical Dermatology and Venereology. 2016;15(6):111‑115. (In Russ.)
https://doi.org/10.17116/klinderma2016156111-115

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Experience of inclusion of remaxol in rehabilitation therapy of patients after radical prostatectomy. P.A. Herzen Journal of Oncology. 2025;(4):54-60

Results of a multicenter international study on the efficacy and safety of Remaxol in patients with drug-induced liver injury during antitumor therapy. P.A. Herzen Journal of Oncology. 2025;(5):26-33

Abstract:

We report the clinical case of pseudoallergic reaction in the form of generalized urticaria. We discuss the issues of therapy of pseudoallergic reactions using membrane stabilizers and antihypoxants in order to normalize diamine oxidase function.

Keywords:

pseudoallergic reaction

histamine

diamine oxidase

Remaxol

Authors:

Sergeeva T.A.

Zhiganova T.A.

SPbGBUZ «Psihonevrologicheskij dispanser №5», Sankt-Peterburg, Rossija, 195176

Close metadata

References:

Jarisch R, Gоtz M, Hemmer W, Missbichler A, Raithel M, Wantke F. Histamin-Intoleranz. Histamin und Seekrankheit. 2 ed. Stuttgart. New York.: Georg Thieme Verlag; 2004
Bieganski T, Kusche J, Lorenz W, Hesterberg R, Stahlknecht CD, Feussner KD. Distribution and properties ofhuman intestinal diamineoxidase and its relevance for the histamine catabolism. Biochim BiophysActa. 1983; 756: 196-203.
Sattler J, Lorenz W. Intestinal diamine oxidases and enteral-induced histaminosis: studies on three prognostic variables in an epidemiological model. J. Neural Transm Suppl. 1990; 32: 291-314.
Steinbrecher I, Jarisch R. Histamin und Kopfschmerz. Allergologie. 2005; 28: 84-91.
Wantke F, Gotz M, Jarisch R: The red wine provocation test:intolerance to histamine as a model for food intolerance. Allergy Proc. 1994; 15: 27-32.
Wantke F, Gotz M, Jarisch R. Histamine-free diet: treatment of choice for histamine-induced food intolerance and supporting treatment for chronic headaches. Clin Exp Allergy. 1993; 23: 982-985.
Matek M, Baenkler HW, Jorde W, Hahn EG. Mucosal histamine content and histamine secretion in Crohn's disease,ulcerative colitis and allergic enteropathy. Int Arch Allergy Immunol. 1995; 108: 127-133.
Jarisch R, Wantke F. Wine and headache. Int Arch Allergy Immunol. 1996; 110: 7-12.
Raithel M, Kufner M, Ulrich P, Hahn EG. The involvement of the histamine degradation pathway by diamine oxidase in manifest gastrointestinal allergies. Inflamm Res. 1999; 48 (Suppl. 1): S75-76.
Schmidt WU, Sattler J, Hesterberg R et al. Human intestinal diamine oxidase (DAO) activity in Crohn's disease: a new marker for disease assessment? Agents Actions. 1990; 30: 267-270.
Petersen J, Drasche A, Raithel M, Schwelberger HG. Analysis of genetic polymorphisms of enzymes involved in histamine metabolism. Inflamm Res. 2003; 52 (Suppl. 1): S69-870.
Schwelberger HG, Drasche A, Petersen J, Raithel M. Genetic polymorphisms of histamine degrading enzymes: from small-scale screening to high-throughput routine testing. Inflamm Res. 2003; 52(Suppl. 1): S71-73.
Naumova OA. Syndrome of decreased tolerance to histamine (part I), Dityachiy Likar. 2013; 3(24): 44-50. (in Russ.)
Kozlov VK, Radchenko VG, Stelmakh VV. Succinate-based metabolic correctors as pathogenetic therapy of chronic hepatitis. Therapevticheskiy Archiv. 2011; 2: 67-71 (in Russ.)
Mischenko SV, Giley AY, Mikheeev EY, Orlov YP. A case of favorable outcome of potentially mortal acute paracetamol poisoning. Clinicheskaya Medicina. 2011; 4: 67-68. (in Russ.)